AstraZeneca

Open: 74.95 Close: 74.73 Change: -0.22

You're running out of time to find out about AstraZeneca using an AI.

The game is changing. There is a new strategy to evaluate AstraZeneca fundamental value, possible risks and most salient advantages. Investors have traditionally relied in reading large amounts of text to evaluate the fundamental value of a stock or company. However, the development of Artificial Intelligence (AI) tools is modifying the way investments are evaluated in markets. Today, machine learning, natural language processing and bigdata allow making this process automatic, reducing large amounts of text to the elements that have a higher activation in a neural network. We programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about AstraZeneca are: AstraZeneca, price, PLC, rise, Argus, ADR, still, and the …

Concept Map

Semantic Network

Stock Summary

AstraZeneca PLC focuses on the discovery, development, manufacture, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa,.

Today's Summary

Astrazeneca appoints Cristian Massacesi as new CMO. Thai PM Prayut Chan-o-cha inoculated with AstraZeneca COVID-19 vaccine. UK government on Thursday defended the Oxford-AstraZeneca Covid-19.

Today's News

AstraZeneca PLC ADR rises Monday, still underperforms market - marketwatch. astrazeneca plc adr rises monday, still. underperform market - MarketWatch. astraZenecas ADR. Astrazeneca appoints Cristian Massacesi as new CMO. Massacei replaces Ann Taylor, who retired this summer after two years as CMO and two decades at Pfizer. The Portfolio Selector features the Argus Focus List, a group of 30 best idea stocks generated and regularly updated by Argus analysts and investment policy committee. AstraZeneca PLC (AZN) has been targeting a price range from $62.5 to $77. The price of AstraZeneca is down -0.13% at $74.63. Argus Research has decided to maintain their Buy rating. Thai PM Prayut Chan-o-cha inoculated with AstraZeneca COVID-19 vaccine. Thai PM inoculated this morning after postponement from last Friday. UK government on Thursday defended the Oxford-AstraZeneca Covid-19. AstraZeneca has been given planning permission for a $360 million (€326 million) “next generation” active pharma ingredient manufacturing facility in north Dublin. The average price target for the company is $80.25, which is 7.39% higher than the current price. AstraZeneca PLC is a science-led biopharmaceutical company. Company has risen 413% over the past month. Astrazeneca plazc has a Long-Term Technical Technical Report.

Stock Profile

"AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company's marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Andexxa/Ondexxya, Atacand, Atacand HCT, Atacand Plus, Brilinta/Brilique, Bydureon/Byetta, BCise, Byetta, Crestor, Evrenzo, Farxiga/Forxiga, Komboglyze/Kombiglyze XR, Lokelma, Onglyza, Qtern, Xigduo/Xigduo, and Zestril XR for cardiovascular, renal, and metabolism diseases; Accolate, Accoleit, Vanticon, Bevespi Aerosphere, Breztri Aerosphere, Bricanyl Respules and Turbuhaler, Daliresp/Daxas, Duaklir Genuair, Fasenra, Pulmicort, Rhinocort, Saphnelo, Symbicort, and Tezspire for respiratory and immunology; and Kanuma, Soliris, Strensiq, and Ultomiris for rare diseases. Its marketed products also comprise Synagis for respiratory syncytial virus; Fluenz Tetra/FluMist Quadrivalent for Influenza; and Vaxzevria and Evusheld for covid-19. The company serves primary care and specialty care physicians through distributors and local representative offices in the United Kingdom, rest of Europe, the Americas, Asia, Africa, and Australasia. It has a collaboration agreement with Neurimmune AG to develop and commercialize NI006; and Personalis, Inc. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom."

Keywords

This document will help you to evaluate AstraZeneca without reading an infinite amount of sources. Relying only on stock quotes or prices to make investment decisions is a mistake. Analyzing and observing stock charts, highs and lows and other numerical data does not allow to evaluate the real value of a company. Stock quotes and prices are the result of underlying characteristics of a company and of events and news happening around them. For this reason, investing must be based on information, not numbers. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about AstraZeneca are: AstraZeneca, price, PLC, rise, Argus, ADR, still, and the most common words in the summary are: astrazeneca, vaccine, covid19, news, stock, company, best, . One of the sentences in the summary was: Thai PM Prayut Chan-o-cha inoculated with AstraZeneca COVID-19 vaccine. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #astrazeneca #vaccine #covid19 #news #stock #company #best.